|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 29.37 USD | +1.73% |
|
+3.09% | +9.67% |
| 07/11 | Amphastar Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 07/11 | Amphastar Pharmaceuticals Insider Sold Shares Worth $814,669, According to a Recent SEC Filing | MT |
| Market Cap | 125.27Cr 113.52Cr 105Cr 95Cr 178.53Cr 12TCr 184.82Cr 1.26TCr 500.14Cr 6.31TCr 470.1Cr 460.13Cr 20TCr | P/E 2026 * |
12.2x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 155.39Cr 140.81Cr 130.24Cr 117.51Cr 221.45Cr 15TCr 229.26Cr 1.56TCr 620.39Cr 7.83TCr 583.12Cr 570.76Cr 25TCr | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.81x |
| Free-Float |
47.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Tradegate
| 29A | Real-time | |
|
Boerse Muenchen
| 29A | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Börse Stuttgart
| 29A | Delayed |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | +1.73% | ||
| 1 week | +3.09% | ||
| Current month | +5.95% | ||
| 1 month | +12.62% | ||
| 3 months | +40.46% | ||
| 6 months | +69.77% | ||
| Current year | +9.67% |
| 1 week | 28.5 |  | 29.73 |
| 1 month | 24.62 | | 31 |
| Current year | 16.64 | | 31 |
| 1 year | 16.64 | | 31 |
| 3 years | 16.64 | | 65.92 |
| 5 years | 16.64 | | 67.66 |
| 10 years | 12.05 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 29/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 29/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/11/26 | Exercice | Chief Financial Officer | 34,631 | 0.0814% | ||
| 21/09/26 | Sell | Chief Financial Officer | -4,139 | 0.0097% | ||
| 16/09/26 | Exercice | Chief Technology Officer | 30,000 | 0.0705% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.73% | +3.09% | +12.70% | -47.84% | 125.27Cr | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,28600Cr | |
| +0.79% | +3.45% | +45.84% | +93.52% | 69TCr | |
| +0.20% | +1.28% | +26.97% | +113.70% | 52TCr | |
| -0.44% | +3.69% | +41.45% | +68.91% | 39TCr | |
| +0.55% | +0.70% | +59.02% | +44.62% | 36TCr | |
| -0.12% | +0.74% | +28.39% | +58.54% | 30TCr | |
| +0.37% | +0.37% | +3.33% | +37.27% | 29TCr | |
| -0.30% | +1.14% | +38.29% | +72.46% | 25TCr | |
| +0.08% | +0.71% | +34.44% | +124.95% | 21TCr | |
| Average | +0.41% | +2.31% | +33.12% | +70.24% | 43TCr | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.69% | +96.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76Cr 69Cr 64Cr 57Cr 108.1Cr 7.15TCr 111.91Cr 763.71Cr 302.83Cr 3.82TCr 284.64Cr 278.6Cr 12TCr | 79Cr 72Cr 66Cr 60Cr 112.94Cr 7.47TCr 116.92Cr 797.9Cr 316.38Cr 3.99TCr 297.38Cr 291.07Cr 13TCr |
| Net income | 10Cr 9.21Cr 8.52Cr 7.68Cr 14Cr 958.07Cr 15Cr 102.31Cr 41Cr 511.78Cr 38Cr 37Cr 1.62TCr | 11Cr 10Cr 9.6Cr 8.66Cr 16Cr 1.08TCr 17Cr 115.31Cr 46Cr 576.82Cr 43Cr 42Cr 1.83TCr |
| Net Debt | 30Cr 27Cr 25Cr 23Cr 43Cr 2.84TCr 44Cr 303.26Cr 120.25Cr 1.52TCr 113.03Cr 110.63Cr 4.82TCr | 18Cr 16Cr 15Cr 14Cr 26Cr 1.71TCr 27Cr 182.12Cr 72Cr 911.03Cr 68Cr 66Cr 2.89TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $29.37 | +1.73% | 3,80,762 |
| 12/26/12 | $28.87 | +0.94% | 3,74,915 |
| 11/26/11 | $28.60 | -1.58% | 4,97,666 |
| 10/26/10 | $29.06 | -1.09% | 4,84,892 |
| 09/26/09 | $29.38 | +3.12% | 6,35,804 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions
